IP
LMAT icon

Intellectus Partners’s LeMaitre Vascular LMAT Stock Holding History

Intellectus Partners’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$223K Buy
+2,040
New +$194K 0.05% 269

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Intellectus Partners's LMAT Position: Q1 2026 in Review

Intellectus Partners opened a new position in LeMaitre Vascular (LMAT) in Q1 2026: 2,040 shares worth $223K. The stake represents 0.05% of the portfolio and ranks #269 among its holdings.

339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Intellectus Partners held 2,040 shares of LeMaitre Vascular worth $223K as of Q1 2026.
  • LeMaitre Vascular was a new Intellectus Partners position in Q1 2026.
  • LeMaitre Vascular made up 0.05% of Intellectus Partners's portfolio in Q1 2026, its #269 holding.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Intellectus Partners's 13F filing for Q1 2026, filed 10 Apr 2026.